Don't miss Joystiq's up-to-the-minute live coverage of E3!

Note: The contents of this blog are for informational purposes only and should not be construed as medical advice or substitute for professional care. For medical emergencies, dial 911!

Posts with tag NationalPublicRadio

Running over the same old ground: exercise and diabetes

Oh yawn, I thought to myself this morning. Upon turning on National Public Radio, I immediately heard what seems to be yet another report on diabetics and exercise. According to the results of a new study, the majority of people with Type 2 diabetes or at risk for it fail to follow through on their doctors' advice to get moving and get some good old-fashioned exercise to ward off the disease - or at least slow its progress. The study comes courtesy of a team of researchers at the University of Colorado, Denver. It's a sizable study, involving over 22,000 patients. The results are being published in Diabetes Care (February 2007) and basically conclude that fewer than forty percent of those advised to get exercise actually do so. Moreover, those most at risk are in fact the least likely to heed exercise advice. Dr. Elaine Morrato, who led both this study and an earlier one on a similar topic, says "People should exercise more, that story is out. What we're saying is, 'Here's a high-risk population that can benefit from exercise, and they're even less likely to exercise.'"

Now, I hate to be a grumpy naysayer, but (to use an exercise-related metaphor) isn't this just a case of running over the same old ground? Is this study really contributing anything new? According to the NPR report, Morrato goes on to say that the results are "very pessimistic," but that she does not know the answer to what is perhaps the real question: how to change peoples' behavior. We already know there is a T2 diabetes epidemic going on. We already know that obesity and inactivity are to blame. Instead of studying the issue over and over, from every conceivable angle, shouldn't researchers be focusing on how to stop this national health train wreck that we're seeing? Am I being unreasonable? You tell me.

The weight-loss lizard: how Byetta gets its bite

National Public Radio (NPR) is running a transcript of its latest report on diabetes treatment options. It's top picks: inhalable insulin (of course, given all the hype!), and also a drug derived from lizard saliva. Hang on. Let's backtrack. Lizard saliva? Turns out, they're talking about the popular diabetes drug Byetta. Yes, the drug that's contained in Byetta is known as exanitide. Byetta has been in the news a great deal in the past because of its unintended, but usually much-welcomed side-effect: weight loss. Exanitide, which mimics a naturally-occurring hormone by stimulating insulin release, is taken from the saliva of the Gila monster (pictured), a large lizard found in the southwest of the US and the northern region of Mexico. It is a venomous little critter, although it's bites are rarely fatal to humans. (Although that's what Steve Irwin thought about sting rays...) Don't ask me how they get the saliva from the Gila monster. I'm afraid I don't want to know...

Still, the NPR report also emphasizes the importance of good old-fashioned exercise and other positive lifestyle changes in managing diabetes. There is also a handy summary chart at the end of the feature explaining who can and cannot use inhalable insulin. If you're confused about this issue, check it out!


Features
Form and Function (12)
Retro Review (7)
Media
Personalities (38)
Blogs (21)
Books (24)
Products (129)
Services (43)
Magazines (12)
Meet the Bloggers
Bloggers (5)
Diane Rixon (1)
Chris Sparling (1)
Allie Beatty (38)
News
Daily News (180)
Events (63)
Fundraisers (23)
Opinion (114)
Prevention
Diet (366)
Exercise (97)
Lifestyle (512)
Research (465)
Treatment
Care (63)
Complications (37)
Drugs (384)
Support (235)
Types of Diabetes
Adult Onset (517)
Childhood (447)
Type 1 (791)
Type 2 (987)

RESOURCES

RSS NEWSFEEDS

Powered by Blogsmith

Other Weblogs Inc. Network blogs you might be interested in: